European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

MT Newswires Live09-26

European equities traded in the US as American depositary receipts were trending higher late Thursday morning, rising 0.49% to 1,443.68 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and financial services company Banco Bilbao Vizcaya Argentaria (BBVA), which rose 4.7% and 3.1%, respectively. They were followed by brewing company Anheuser-Busch InBev (BUD) and financial services company Banco Santander (SAN), which were up 2.9% and 2.7%, respectively.

The decliners from continental Europe were led by internet advertising firm Criteo (CRTO) and semiconductor company Sequans Communications (SQNS), which dropped 7.7% and 2.7%, respectively. They were followed by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which lost 2.6% and 2.3%, respectively.

From the UK and Ireland, the gainers were led by insurance firm Prudential (PUK) and alcoholic beverage company Diageo (DEO), which advanced 7.4% and 5%, respectively. They were followed by mining company BHP Group (BHP) and cruise line operator Carnival (CUK), which increased 4% and 3.8%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana (NCNA) and Akari Therapeutics (AKTX), which shed 6.9% and 6.8%, respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and TC Biopharm (TCBP), which fell 6.7% and 5.3%, respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment